What We Talk about When We Talk about Artificial Intelligence in Radiation Oncology
- PMID: 36579551
- PMCID: PMC9694457
- DOI: 10.3390/jpm12111834
What We Talk about When We Talk about Artificial Intelligence in Radiation Oncology
Abstract
The constant evolution of technology has dramatically changed the history of radiation oncology, allowing clinicians to deliver increasingly accurate and precise treatments, moving from 2D radiotherapy to 3D conformal radiotherapy, leading to intensity-modulated image-guided (IMRT-IGRT) and stereotactic body radiotherapy treatments [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Cusumano D., Dinapoli N., Boldrini L., Chiloiro G., Gatta R., Masciocchi C., Lenkowicz J., Casà C., Damiani A., Azario L., et al. Fractal-based radiomic approach to predict complete pathological response after chemo-radiotherapy in rectal cancer. Radiol. Med. 2018;123:286–295. doi: 10.1007/s11547-017-0838-3. - DOI - PubMed
-
- Chiloiro G., Boldrini L., Preziosi F., Cusumano D., Yadav P., Romano A., Placidi L., Lenkowicz J., Dinapoli N., Bassetti M.F., et al. A Predictive Model of 2yDFS During MR-Guided RT Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients. Front. Oncol. 2022;12:831712. doi: 10.3389/fonc.2022.831712. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
